Advertisement
TwistDx
TwistDx

The Scientist

» industry and cell & molecular biology

Most Recent

image: Prominent Cell Biologist Dies

Prominent Cell Biologist Dies

By | May 4, 2015

Cytoskeleton specialist Alan Hall was best known for unpacking the roles of Rho GTPases.   

0 Comments

image: Follow the Funding

Follow the Funding

By | May 1, 2015

In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.  

8 Comments

image: Think Before You Fire

Think Before You Fire

By | May 1, 2015

Industry layoffs may save a few dollars, at the cost of losing the collective brainpower of thousands of scientists.

3 Comments

image: Drugmaker Teva Bids $40 Billion for Mylan

Drugmaker Teva Bids $40 Billion for Mylan

By | April 23, 2015

The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.

0 Comments

image: Cellular Garbage Disposal Illuminated

Cellular Garbage Disposal Illuminated

By | April 13, 2015

A Harvard team shows how cells label and recognize proteins for degradation.

0 Comments

image: 2015 Top 10 Innovations: Enter Today!

2015 Top 10 Innovations: Enter Today!

By | April 13, 2015

Submissions are officially open for this year’s Top 10 Innovations contest.

0 Comments

image: A Benefit of Failed Pregnancy?

A Benefit of Failed Pregnancy?

By | April 9, 2015

Scientists find a common genetic variant in mothers that decreases the chance of successful pregnancy.

7 Comments

image: Another CAR-T IPO

Another CAR-T IPO

By | April 6, 2015

Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.

0 Comments

image: Book Excerpt from <em>p53</em>

Book Excerpt from p53

By | April 1, 2015

In Chapter 12, "Of Mice and Men," author Sue Armstrong recounts the point at which researchers moved from working with p53 in tissue culture to studying the gene in animal models.

0 Comments

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

0 Comments

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Antibiotic Resistance Can Boost Bacterial Fitness
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement
The Scientist